Enliven Therapeutics所有资讯

Enliven Therapeutics | 144：拟议出售证券

01/14 16:08 (美东)

Enliven Therapeutics | 144：拟议出售证券

01/14 16:03 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Patel Anish

01/10 17:36 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

01/07 16:49 (美东)

Enliven Therapeutics | 144：拟议出售证券

01/07 16:24 (美东)

Enliven Therapeutics | 144：拟议出售证券

01/03 16:08 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

12/31 17:21 (美东)

Enliven Therapeutics | 144：拟议出售证券

2024/12/27 16:38 (美东)

Enliven Therapeutics | 144：拟议出售证券

2024/12/16 16:34 (美东)

Enliven Therapeutics | 144：拟议出售证券

2024/12/16 16:19 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

2024/12/02 17:21 (美东)

Enliven Therapeutics | 144：拟议出售证券

2024/11/15 16:39 (美东)

Enliven Therapeutics | 144：拟议出售证券

2024/11/15 16:33 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(2.2%),Peter Kolchinsky(2.2%)等

2024/11/14 17:53 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(8.5%),VHCP Co-Investment Holdings III, LLC(8.5%)等

2024/11/14 17:51 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%)等

2024/11/14 16:29 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%)等

2024/11/14 16:23 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(8.7%),Commodore Capital Master LP(8.7%)

2024/11/14 16:15 (美东)

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)

2024/11/13 17:57 (美东)

Enliven Therapeutics | 10-Q：2024财年三季报

2024/11/13 16:20 (美东)